India aims to be tuberculosis-free by 2025, five years ahead of worldwide targets
India has pledged its commitment to eliminate tuberculosis by 2025, five years ahead of the global goal to reduce the number of such deaths by 90 percent by 2030
New Delhi: India has pledged its commitment to eliminate tuberculosis by 2025, five years ahead of the global goal to reduce the number of such deaths by 90 percent by 2030.
Speaking at the 29th meeting of 'Stop TB Partnership' coordination committee, Union health minister JP Nadda said that India has formulated a national strategic plan with a special focus on stamping out the bactrial disease at grassroot levels.
"We have implemented daily drug regimen for treating tuberculosis (TB) in five states, and by the year-end it would be rolled out in the entire country," Nadda said.
The new regimen helps in reducing relapse rates and number of drug-resistant TB cases, he said.
Nadda said that at present 628 Cartridge Based Nucleic Acid Amplification Test (CBNAAT) machines are functioning in the country for quick diagnosis of TB and the ministry will procure 500 more equipments which diagnoses TB within two hours.
The CBNAAT is a revolutionary rapid molecular test which detects Mycobacterium tuberculosis and rifampicin drug resistance, simultaneously.
He further said that the government will frame special programmes to combat multidrug-resistant TB. Later, in a tweet, the minister said the he met the Netherlands' state secretary in the Ministry of Health, to discuss possibilities of cooperation in Antimicrobial resistance (AMR).
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
Molecular testing is a crucial tool for diagnosis, insights to lower antimicrobial resistance burden
The utility of molecular testing has been released in the current COVID-19 pandemic, with RT-PCR becoming a household name.
As race to COVID-19 vaccine heats up, a look at major jabs, development and clinical trials underway
According to WHO, there are 48 COVID-19 vaccine candidates are undergoing clinical evaluation, of which eleven are at late-stage trials, whereas, 164 candidate vaccines are in preclinical evaluation
COVID-19 vaccine to reach 30 cr by July-Aug, says Harsh Vardhan; healthcare workers, people above 65 yrs priority
Stating that everything is being decided by experts with a scientific point of view, the Union health minister expressed confidence that the COVID-19 vaccine will be ready in the next three to four months